| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.057 | 0.3 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.3 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.3 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.3 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.054 | 0.3 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |